Nawroth P P, Rudofsky G, Humpert P
Universität Heidelberg, Innere Medizin I und Klinische Chemie, Heidelberg, Germany.
Exp Clin Endocrinol Diabetes. 2010 Jan;118(1):1-3. doi: 10.1055/s-0029-1246117. Epub 2010 Feb 1.
Recently published data examining the role of the metabolic syndrome and obesity in cardiovascular disease rendered surprising results. In addition, other studies revealed that there is more to diabetes therapy than lowering blood glucose, which might under certain circumstances even harm patients. In the light that we now know that "death" is as important an endpoint in diabetes as in other diseases, new tools--better than the oral glucose tolerance test--are required to identify the patients at risk, as are additional standards in individualized therapy. A critical view on old concepts is necessary.
最近发表的研究代谢综合征和肥胖在心血管疾病中作用的数据得出了惊人的结果。此外,其他研究表明,糖尿病治疗不仅仅是降低血糖,在某些情况下,降低血糖甚至可能对患者有害。鉴于我们现在知道“死亡”在糖尿病中与在其他疾病中一样是一个重要的终点,需要有比口服葡萄糖耐量试验更好的新工具来识别有风险的患者,个性化治疗中也需要有更多的标准。对旧观念进行批判性审视是必要的。